Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses
Chang Yi Wang, Wen‐Jiun Peng, Be-Sheng Kuo, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1010870-e1010870
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant
Rofhiwa Nesamari, Millicent A. Omondi, Richard Baguma, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 162-169.e3
Open Access | Times Cited: 31
mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies
Brian Montoya, Carolina R. Melo‐Silva, Lingjuan Tang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1790-1804
Open Access | Times Cited: 5
UB-612 pan-SARS-CoV-2 T cell immunity-promoting vaccine protects against COVID-19 moderate-severe disease
Chang Yi Wang, Be-Sheng Kuo, Yu-Hsiang Lee, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108887-108887
Open Access | Times Cited: 4
Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing
Puja Jaishwal, Kisalay Jha, Satarudra Prakash Singh
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134012-134012
Closed Access | Times Cited: 4
Bioinformatic identification of Conserved epitopes from SARS-COV-2 genome isolated in Kenya
Elius Mbogori, Stanslaus Musyoki, Richard Biegon, et al.
Next research. (2025), pp. 100215-100215
Closed Access
The Immunogenicity of CpG, MF59-Like, and Alum Adjuvant Delta Strain Inactivated SARS-CoV-2 Vaccines in Mice
Kangwei Xu, Jing Li, Lu Xu, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 60-60
Open Access | Times Cited: 3
Reverse vaccinology-based multi-epitope COVID-19 vaccine targeting SARS-CoV-2 structural and non-structural proteins induces immune responses in mice
Azzania Fibriani, Nicholas Yamahoki, Adi Shani, et al.
Vaccine X (2025), pp. 100632-100632
Open Access
Rerouting therapeutic peptides and unlocking their potential against SARS-CoV2
Namrata Prashar, Sameer Khairullah MOHAMMED, Raja Natesan Sella, et al.
3 Biotech (2025) Vol. 15, Iss. 5
Closed Access
Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern
Ankita Saha, Sounak Ghosh Roy, Richa Dwivedi, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 424-424
Open Access
Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7
Yanfang Zhang, Xinrui Kang, Sheng Liu, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 9, pp. e1011659-e1011659
Open Access | Times Cited: 8
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection
Sabrina Clever, Leonard Limpinsel, Christian Meyer zu Natrup, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 417-417
Open Access | Times Cited: 2
Boosting PRRSV-Specific Cellular Immunity: The Immunological Profiling of an Fc-Fused Multi-CTL Epitope Vaccine in Mice
Xinnuo Lei, Jinzhao Ban, Zhi Wu, et al.
Veterinary Sciences (2024) Vol. 11, Iss. 6, pp. 274-274
Open Access | Times Cited: 2
Enhanced Assessment of Cross-Reactive Antigenic Determinants within the Spike Protein
Guilherme C. Lechuga, Jairo R. Temerozo, Paloma Napoleão-Pêgo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8180-8180
Open Access | Times Cited: 2
The development and application of pseudoviruses: assessment of SARS-CoV-2 pseudoviruses
Conglian Tan, Nian Wang, Shanshan Deng, et al.
PeerJ (2023) Vol. 11, pp. e16234-e16234
Open Access | Times Cited: 4
Spike S2 Subunit: Possible Target for Detecting Novel SARS-CoV-2 Variants with Multiple Mutations
Teerada Ponpinit, Yutthana Joyjinda, Weenassarin Ampoot, et al.
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 2, pp. 50-50
Open Access | Times Cited: 1
The Papain-like Protease Domain of Severe Acute Respiratory Syndrome Coronavirus 2 Conjugated with Human Beta-Defensin 2 and Co1 Induces Mucosal and Systemic Immune Responses against the Virus
Byeol-Hee Cho, Ju Kim, Yong‐Suk Jang
Vaccines (2024) Vol. 12, Iss. 4, pp. 441-441
Open Access | Times Cited: 1
Humoral Response to Dengue Virus Infections Potentiates Antibody-Dependent Enhancement of SARS-CoV-2
Guilherme C. Lechuga, Jairo R. Temerozo, Paloma Napoleão-Pêgo, et al.
(2023)
Open Access | Times Cited: 2
Delivery of SARS-CoV-2 spike and membrane genes in a single Baculoviral vector enhance the immune breadth against SARS-CoV-2 variants of concern
Jungmin Chun, Do‐Young Yoon, Aleksandra Nowakowska, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126355-126355
Closed Access
Identification of potential antigenic proteins and epitopes for the development of a monkeypox virus vaccine: an in silico approach
Emre Aktaş, Uğur Sezerman, Murat Özer, et al.
Molecular Diversity (2024)
Closed Access
Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice
Jacklyn R. Hurst, Maedeh Naghibosadat, Patrick Budowski, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0314061-e0314061
Open Access
The Quantification of Spike Proteins in the Inactivated SARS-CoV-2 Vaccines of the Prototype, Delta, and Omicron Variants by LC–MS
Kangwei Xu, Huang Sun, Kaiqin Wang, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 1002-1002
Open Access | Times Cited: 1
Exploration of the cross-immunity between SARS-CoV and SARS-CoV-2 in mice
Shuhui Wang, Li Ren, Ying Liu, et al.
Future Virology (2024)
Closed Access
Bioinformatic Identification of Conserved Epitopes from Sars-Cov-2 Genome Isolated in Kenya
Elius Mbogori, Stanslaus Musyoki, Richard Biegon, et al.
(2024)
Closed Access
A Universal Multi-Epitope Vaccine Design Against Porcine Reproductive and Respiratory Syndrome Virus via Bioinformatics and Immunoinformatics Approaches
Xinnuo Lei, Zhi Wu, Qi Feng, et al.
Veterinary Sciences (2024) Vol. 11, Iss. 12, pp. 659-659
Open Access
Targeting Multiple Conserved T-Cell Epitopes for Protection against COVID-19 Moderate-Severe Disease by a Pan-Sarbecovirus Vaccine
Chang Yi Wang, Be-Sheng Kuo, Yu‐Hsiang Lee, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1 - Next Page

Scroll to top